World Journal of Hepatology

Non-alcoholic fatty liver disease (NAFLD) or metabolic (dysfunction)-associated fatty liver disease is the leading cause of chronic liver diseases defined as a disease spectrum comprising hepatic steatosis, non-alcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis, and hepatic carcinoma. NASH, characterized by hepatocyte injury, steatosis, inflammation, and fibrosis, is associated with NAFLD prognosis. Ductular reaction (DR) is a common compensatory reaction associated with liver injury, which involves the hepatic progenitor cells (HPCs), hepatic stellate cells, myofibroblasts, inflammatory cells (such as macrophages), and their secreted substances. Recently, several studies have shown that the extent of DR parallels the stage of NASH and fibrosis. This review summarizes previous research on the correlation between DR and NASH, the potential interplay mechanism driving HPC differentiation, and NASH progression.

[1]  S. Glaser,et al.  Pathophysiological Roles of Ductular Reaction in Liver Inflammation and Hepatic Fibrogenesis , 2022, Cellular and molecular gastroenterology and hepatology.

[2]  P. J. Kausalya,et al.  ZO-2/Tjp2 suppresses Yap and Wwtr1/Taz-mediated hepatocyte to cholangiocyte transdifferentiation in the mouse liver , 2022, npj Regenerative Medicine.

[3]  Á. Valverde,et al.  Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC‐induced cholestatic injury by promoting a pro‐restorative inflammatory response , 2022, The Journal of pathology.

[4]  B. Wegiel,et al.  Heme oxygenase-1 mitigates liver injury and fibrosis via modulation of LNX1/Notch1 pathway in myeloid cells , 2022, iScience.

[5]  A. Franchitto,et al.  Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes. , 2022, Journal of hepatology.

[6]  H. Kautiainen,et al.  Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis , 2022, Histopathology.

[7]  A. Wree,et al.  NOD‐like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH , 2022, Hepatology.

[8]  L. Fabris,et al.  The Neglected Role of Bile Duct Epithelial Cells in NASH , 2021, Seminars in Liver Disease.

[9]  S. Ghose,et al.  Survivin expression is essential for early activation of hepatic stellate cells and fibrosis progression in chronic liver injury. , 2021, Life sciences.

[10]  A. Bell,et al.  β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction , 2021, bioRxiv.

[11]  R. Bataller,et al.  Ductular reaction promotes intrahepatic angiogenesis through Slit2–Roundabout 1 signaling , 2021, Hepatology.

[12]  S. Glaser,et al.  Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease , 2021, Cells.

[13]  S. Glaser,et al.  Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling , 2021, Hepatology.

[14]  K. Ryan,et al.  Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver , 2021, Science Advances.

[15]  S. Forbes,et al.  Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation , 2021, NPJ Regenerative medicine.

[16]  S. Glaser,et al.  Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes , 2021, Hepatology.

[17]  G. Alpini,et al.  Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice Through Mast Cell–Derived Transforming Growth Factor Beta 1 Signaling , 2021, Hepatology.

[18]  J. Gerlach,et al.  Characterization of CD326-positive human hepatic stem cells , 2021, Clinical and experimental hepatology.

[19]  Y. Abou Monsef,et al.  Immunohistochemical evaluation of hepatic progenitor cells in different types of feline liver diseases , 2021, The Journal of veterinary medical science.

[20]  A. Dhawan,et al.  NAFLD to MAFLD in adults but the saga continues in children: an opportunity to advocate change.: Letter regarding "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement". , 2021, Journal of hepatology.

[21]  P. Sakhuja,et al.  Differentiating Biliary Atresia From Idiopathic Neonatal Hepatitis: A Novel Keratin 7 Based Mathematical Approach on Liver Biopsies , 2021, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[22]  S. Glaser,et al.  Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet , 2021, Hepatology.

[23]  M. Gantier,et al.  Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells , 2020, Stem cell research & therapy.

[24]  Baowei Hu,et al.  Shh‐Yap signaling controls hepatic ductular reactions in CCl4‐induced liver injury , 2020, Environmental toxicology.

[25]  S. Chakraborty,et al.  The Apelin–Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis , 2020, Hepatology.

[26]  R. Schwabe,et al.  Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis , 2020 .

[27]  J. Gil,et al.  Blunting senescence boosts liver regeneration , 2020, Genes & development.

[28]  A. Franchitto,et al.  Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis , 2020, Cells.

[29]  C. Ponting,et al.  Resolving the fibrotic niche of human liver cirrhosis at single cell level , 2019, Nature.

[30]  A. Feldstein,et al.  NAFLD in children: new genes, new diagnostic modalities and new drugs , 2019, Nature Reviews Gastroenterology & Hepatology.

[31]  S. Cockell,et al.  High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease , 2019, The Journal of pathology.

[32]  D. Broadwater,et al.  Hepatic mast cell concentration directly correlates to stage of fibrosis in NASH. , 2019, Human pathology.

[33]  K. Cusi,et al.  Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. , 2019, The lancet. Diabetes & endocrinology.

[34]  S. Forbes,et al.  Hepatocyte‐Specific β‐Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes , 2019, Hepatology.

[35]  S. Glaser,et al.  Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances , 2018, Hepatology.

[36]  R. Schwabe,et al.  Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis , 2018, Science Translational Medicine.

[37]  D. Schuppan,et al.  The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis , 2018, Nature Reviews Gastroenterology & Hepatology.

[38]  J. Gil,et al.  Mechanisms and functions of cellular senescence. , 2018, The Journal of clinical investigation.

[39]  D. Schuppan,et al.  Determinants of fibrosis progression and regression in NASH. , 2018, Journal of hepatology.

[40]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[41]  G. Alpini,et al.  Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling. , 2017, The American journal of pathology.

[42]  R. Fiorotto,et al.  Notch signaling and progenitor/ductular reaction in steatohepatitis , 2017, PloS one.

[43]  Qifan Zhang,et al.  Advanced oxidation protein products induce S-phase arrest of hepatocytes via the ROS-dependent, β-catenin-CDK2-mediated pathway , 2017, Redox biology.

[44]  Caroline L. Wilson,et al.  Cellular senescence drives age-dependent hepatic steatosis , 2017, Nature Communications.

[45]  F. Meng,et al.  Bile duct ligation–induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell–deficient KitW‐sh mice , 2017, Hepatology.

[46]  S. Friedman,et al.  Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.

[47]  G. Guo,et al.  Role of FXR in Liver Inflammation During Nonalcoholic Steatohepatitis , 2017, Current Pharmacology Reports.

[48]  S. Forbes,et al.  Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis. , 2016, Immunity.

[49]  G. Carpino,et al.  The hepatic, biliary, and pancreatic network of stem/progenitor cell niches in humans: A new reference frame for disease and regeneration , 2016, Hepatology.

[50]  A. Franchitto,et al.  Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway , 2016, PloS one.

[51]  H. Cortez‐Pinto,et al.  Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. , 2015, Journal of hepatology.

[52]  O. Barbier,et al.  Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease , 2015, Scientific Reports.

[53]  A. Cole,et al.  Hepatic progenitor cells of biliary origin with liver repopulation capacity , 2015, Nature Cell Biology.

[54]  S. Dooley,et al.  Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds. , 2015, Journal of hepatology.

[55]  Katsutoshi Tokushige,et al.  Diagnosis and classification of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: Current concepts and remaining challenges , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[56]  R. Evans,et al.  Characterization of Distinct Subpopulations of Hepatic Macrophages in HFD/Obese Mice , 2014, Diabetes.

[57]  P. Yuan,et al.  Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression , 2014, Oncogene.

[58]  Patrick Cahan,et al.  Hippo Pathway Activity Influences Liver Cell Fate , 2014, Cell.

[59]  Frank Tacke,et al.  Macrophage heterogeneity in liver injury and fibrosis. , 2014, Journal of hepatology.

[60]  A. Miyajima,et al.  Liver regeneration by stem/progenitor cells , 2014, Hepatology.

[61]  K. Irvine,et al.  The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease , 2014, Hepatology.

[62]  G. Alexander,et al.  Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease , 2014, Cell cycle.

[63]  Lixin Wei,et al.  Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma , 2014, BMC Cancer.

[64]  S. Forbes,et al.  Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. , 2014, Gastroenterology.

[65]  R. Schwabe,et al.  Fate-tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its etiology , 2013, Nature Communications.

[66]  S. Dooley,et al.  IFN-γ inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice. , 2013, Journal of hepatology.

[67]  R. Schwabe,et al.  Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice , 2013, Hepatology.

[68]  R. Fiorotto,et al.  Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice. , 2013, Journal of Hepatology.

[69]  S. Forbes,et al.  Differentiation of progenitors in the liver: a matter of local choice. , 2013, The Journal of clinical investigation.

[70]  A. Franchitto,et al.  Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease , 2012, Hepatology.

[71]  T. Kono,et al.  Aberrant cytokeratin 7 expression of centrilobular hepatocytes: a clinicopathological study , 2012, Histopathology.

[72]  Konrad Basler,et al.  The many faces and functions of β‐catenin , 2012, The EMBO journal.

[73]  K. Lipson,et al.  CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis , 2012, Fibrogenesis & tissue repair.

[74]  A. Suzuki,et al.  Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease , 2012, Hepatology.

[75]  G. Karaca,et al.  NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease , 2012, Gut.

[76]  T. Roskams,et al.  Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease , 2012, Nature Medicine.

[77]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[78]  H. Takikawa,et al.  Histopathological characteristics of non‐alcoholic fatty liver disease in children: Comparison with adult cases , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[79]  A. Gouw,et al.  Ductular reactions in human liver: Diversity at the interface , 2011, Hepatology.

[80]  L. Ferrell,et al.  Centrizonal Arteries and Microvessels in Nonalcoholic Steatohepatitis , 2011, The American journal of surgical pathology.

[81]  Raj Vuppalanchi,et al.  Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. , 2011, Journal of hepatology.

[82]  R. Wells,et al.  Lineage tracing demonstrates no evidence of cholangiocyte epithelial‐to‐mesenchymal transition in murine models of hepatic fibrosis , 2011, Hepatology.

[83]  J. Shu,et al.  In vitro generation of myofibroblasts-like cells from liver epithelial progenitor cells of rhesus monkey (Macaca mulatta) , 2011, In Vitro Cellular & Developmental Biology - Animal.

[84]  V. Desmet.  Ductal plates in hepatic ductular reactions. Hypothesis and implications. II. Ontogenic liver growth in childhood , 2011, Virchows Archiv.

[85]  V. Desmet.  Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered , 2011, Virchows Archiv.

[86]  A. Diehl,et al.  The role of Hedgehog signaling in fibrogenic liver repair. , 2011, The international journal of biochemistry & cell biology.

[87]  A. Diehl,et al.  Hedgehog signaling in the liver. , 2011, Journal of hepatology.

[88]  G. Karaca,et al.  Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis , 2011, Hepatology.

[89]  J. Hart,et al.  Aberrant expression of cytokeratin 7 in perivenular hepatocytes correlates with a cholestatic chemistry profile in patients with heart failure , 2010, Modern Pathology.

[90]  G. Marchesini,et al.  Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C , 2010, Gut.

[91]  Rachel M. Brown,et al.  Heterogeneity of fibrosis patterns in non‐alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[92]  E. Turányi,et al.  Immunohistochemical classification of ductular reactions in human liver , 2010, Histopathology.

[93]  G. Yeoh,et al.  Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury. , 2010, Journal of hepatology.

[94]  G. Karaca,et al.  Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease , 2010, Hepatology.

[95]  K. Samuel,et al.  Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver , 2010, Gut.

[96]  R. Premont,et al.  Signals from dying hepatocytes trigger growth of liver progenitors , 2010, Gut.

[97]  P. Northcott,et al.  YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. , 2009, Genes & development.

[98]  A. Diehl,et al.  Epithelial‐to‐mesenchymal transitions in the liver , 2009, Hepatology.

[99]  T. Roskams,et al.  Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling , 2009, Gut.

[100]  G. Karaca,et al.  Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. , 2009, Gastroenterology.

[101]  H. Tilg,et al.  Role for hedgehog pathway in regulating growth and function of invariant NKT cells , 2009, European journal of immunology.

[102]  V. Alves,et al.  A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. , 2008, Journal of hepatology.

[103]  D. Schuppan,et al.  Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. , 2008, The Journal of clinical investigation.

[104]  R. Ahima,et al.  Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. , 2008, American Journal of Physiology. Endocrinology and Metabolism.

[105]  S. Majumdar,et al.  Macaca radiata (bonnet monkey): a spontaneous model of nonalcoholic fatty liver disease , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[106]  Liang Tang,et al.  Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. , 2008, Cancer research.

[107]  Buzz Baum,et al.  Transitions between epithelial and mesenchymal states in development and disease. , 2008, Seminars in cell & developmental biology.

[108]  S. Dooley,et al.  Transforming growth factor‐β and hepatocyte transdifferentiation in liver fibrogenesis , 2008, Journal of gastroenterology and hepatology.

[109]  C. Guha,et al.  Identification of adult hepatic progenitor cells capable of repopulating injured rat liver , 2007, Hepatology.

[110]  H. Tilg,et al.  Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. , 2007, Gastroenterology.

[111]  N. Theise,et al.  The tissue biology of ductular reactions in human chronic liver disease. , 2007, Gastroenterology.

[112]  J. Sicklick,et al.  Hedgehog-mediated mesenchymal–epithelial interactions modulate hepatic response to bile duct ligation , 2007, Laboratory Investigation.

[113]  F. Kondo,et al.  Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules , 2007, Cancer.

[114]  R. Bataller,et al.  Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. , 2006, The American journal of pathology.

[115]  T. Roskams,et al.  Liver regeneration in acute severe liver impairment: a clinicopathological correlation study , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[116]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[117]  Youhua Liu,et al.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. , 2006, The American journal of pathology.

[118]  C. Nievergelt,et al.  Histopathology of pediatric nonalcoholic fatty liver disease , 2005, Hepatology.

[119]  M. Richardson,et al.  Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis , 2005, Hepatology.

[120]  H. Tilg,et al.  Adiponectin and its receptors in non-alcoholic steatohepatitis , 2004, Gut.

[121]  Shin Mi Park,et al.  Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis. , 2004, Journal of hepatology.

[122]  M. Maeda,et al.  Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. , 2004, Immunity.

[123]  A. Miyajima,et al.  Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors , 2004, Journal of Cell Science.

[124]  A. West,et al.  Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers , 2004, Hepatology.

[125]  S. Thorgeirsson,et al.  2‐acetylaminofluorene dose‐dependent differentiation of rat oval cells into hepatocytes: Confocal and electron microscopic studies , 2004, Hepatology.

[126]  K. Zatloukal,et al.  Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. , 2003, Gastroenterology.

[127]  V. Paradis,et al.  Liver extracellular matrix in health and disease , 2003, The Journal of pathology.

[128]  Yu Wang,et al.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.

[129]  F. Marra,et al.  Chemokines in liver inflammation and fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.

[130]  L. Gresh,et al.  Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. , 2002, Development.

[131]  T. Roskams,et al.  The onecut transcription factor HNF6 is required for normal development of the biliary tract. , 2002, Development.

[132]  S. Glaser,et al.  Functional heterogeneity of the intrahepatic biliary epithelium , 2000, Hepatology.

[133]  H. Herbst,et al.  Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. , 1999, Journal of hepatology.

[134]  T. Ohtsuka,et al.  Hes1 and Hes5 as Notch effectors in mammalian neuronal differentiation , 1999, The EMBO journal.

[135]  F. Marra,et al.  Monocyte chemotactic protein‐1 as a chemoattractant for human hepatic stellate cells , 1999, Hepatology.

[136]  T. Honjo,et al.  Roles of the ankyrin repeats and C-terminal region of the mouse notch1 intracellular region. , 1998, Nucleic acids research.

[137]  M. Hanani,et al.  Biliary Tract , 1987, Current opinion in radiology.

[138]  L. Henry,et al.  NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .

[139]  M. Westerhoff,et al.  Centrilobular ductular reaction correlates with fibrosis stage and fibrosis progression in non-alcoholic steatohepatitis , 2018, Modern Pathology.

[140]  S. Glaser,et al.  Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. , 2007, Gastroenterology.

[141]  H. Yoshimatsu,et al.  Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. , 2004, Hepatology.

[142]  D. Pessayre,et al.  Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. , 1997, Journal of hepatology.